Susquehanna International Group’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$110M Buy
665,300
+149,900
+29% +$24.6M 0.01% 769
2025
Q4
$82.1M Buy
515,400
+55,000
+12% +$7.55M 0.01% 1013
2025
Q3
$43.1M Sell
460,400
-306,100
-40% -$21.6M ﹤0.01% 1459
2025
Q2
$43.6M Buy
766,500
+395,700
+107% +$21M 0.01% 1258
2025
Q1
$22.6M Buy
370,800
+6,400
+2% +$545K ﹤0.01% 1639
2024
Q4
$32.8M Sell
364,400
-8,900
-2% -$1.05M ﹤0.01% 1446
2024
Q3
$48.1M Buy
373,300
+28,000
+8% +$3.65M 0.01% 1116
2024
Q2
$39.2M Sell
345,300
-158,100
-31% -$16.9M 0.01% 1150
2024
Q1
$66.8M Sell
503,400
-823,300
-62% -$107M 0.01% 859
2023
Q4
$162M Buy
1,326,700
+1,282,205
+2,882% +$98.1M 0.03% 484
2023
Q3
$3.39M Sell
44,495
-15,295
-26% -$1.57M ﹤0.01% 4173
2023
Q2
$7.08M Buy
59,790
+5,835
+11% +$727K ﹤0.01% 2989
2023
Q1
$5.32M Sell
53,955
-181,275
-77% -$24.6M ﹤0.01% 3383
2022
Q4
$33.3M Buy
235,230
+50,550
+27% +$7.05M 0.01% 1132
2022
Q3
$25.9M Sell
184,680
-20,990
-10% -$3.85M 0.01% 1208
2022
Q2
$27.7M Buy
205,670
+68,845
+50% +$11.7M 0.01% 1205
2022
Q1
$42.9M Buy
136,825
+92,035
+205% +$34.7M 0.01% 1087
2021
Q4
$32.2M Buy
44,790
+7,435
+20% +$7.12M ﹤0.01% 1417
2021
Q3
$41.3M Buy
37,355
+5,260
+16% +$6.46M 0.01% 1305
2021
Q2
$47.3M Buy
32,095
+2,305
+8% +$3.2M 0.01% 1233
2021
Q1
$47M Buy
29,790
+9,925
+50% +$23.2M 0.01% 1147
2020
Q4
$39.9M Sell
19,865
-14,010
-41% -$22.3M 0.01% 1154
2020
Q3
$36.3M Buy
33,875
+3,985
+13% +$4.57M 0.01% 1048
2020
Q2
$35.5M Buy
29,890
+15,725
+111% +$13.6M 0.01% 1013
2020
Q1
$6.39M Sell
14,165
-11,920
-46% -$10.8M ﹤0.01% 2271
2019
Q4
$30M Buy
26,085
+15,640
+150% +$14M 0.01% 1119
2019
Q3
$6.46M Sell
10,445
-2,315
-18% -$1.92M ﹤0.01% 2417
2019
Q2
$12.8M Buy
12,760
+6,825
+115% +$6.61M ﹤0.01% 1655
2019
Q1
$7.11M Sell
5,935
-4,310
-42% -$4.48M ﹤0.01% 2073
2018
Q4
$6.73M Buy
10,245
+6,680
+187% +$7M ﹤0.01% 1962
2018
Q3
$6.63M Sell
3,565
-5,325
-60% -$10.5M ﹤0.01% 2348
2018
Q2
$16.9M Buy
8,890
+2,525
+40% +$4.45M 0.01% 1435
2018
Q1
$10.1M Sell
6,365
-4,485
-41% -$8.35M ﹤0.01% 1755
2017
Q4
$16.9M Buy
10,850
+1,150
+12% +$1.76M 0.01% 1384
2017
Q3
$16.6M Buy
9,700
+2,445
+34% +$3.39M 0.01% 1363
2017
Q2
$9.15M Buy
7,255
+4,270
+143% +$4.31M ﹤0.01% 1770
2017
Q1
$2.85M Sell
2,985
-7,710
-72% -$6.87M ﹤0.01% 3113
2016
Q4
$6.7M Sell
10,695
-12,060
-53% -$9.06M ﹤0.01% 2012
2016
Q3
$22.2M Buy
22,755
+20,590
+951% +$17M 0.01% 939
2016
Q2
$1.22M Buy
2,165
+650
+43% +$407K ﹤0.01% 4453
2016
Q1
$831K Buy
1,515
+1,290
+573% +$816K ﹤0.01% 5462
2015
Q4
$381K Buy
+225
New +$364K ﹤0.01% 7272

Other funds holding LABU

Susquehanna International Group's LABU Position: Q1 2026 in Review

Susquehanna International Group increased its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 24% in Q1 2026, buying an estimated $2.12M and bringing the position to 67,050 shares worth $11.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2955.

Susquehanna International Group first reported a position in LABU in Q2 2015 and has held it in 31 quarters since. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.

  • Susquehanna International Group held 67,050 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $11.1M as of Q1 2026.
  • Susquehanna International Group bought 12,910 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2026, an estimated $2.12M.
  • Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2955 holding.
  • Susquehanna International Group first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2015 and has held it in 31 quarters since.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.